TEAM (Thiotepa, Etoposide, Cytarabine, Melphalan) as conditioning regimen for lymphoma treatment with autologous haematopoietic stem cell transplantation

被引：0
|
作者：
Carella, A. M. [1 ]
Palumbo, G. [2 ]
Greco, M. M. [1 ]
Merla, E. [1 ]
Dell'Olio, M. [1 ]
Pisapia, G. [3 ]
Mazza, P. [3 ]
Ferrara, F. [4 ]
Musto, P. [5 ]
Rana, A. [6 ]
Guarini, A. [6 ]
Di Tonno, P. [7 ]
Pastore, D. [8 ]
D'Elia, M. [8 ]
Specchia, G. [8 ]
Capalbo, S. [2 ]
Cascavilla, N. [1 ]
机构：
[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[2] United Hosp, Foggia, Italy
[3] Hosp G Moscati, Taranto, Italy
[4] Hosp Cardarelli, Naples, Italy
[5] CROB, Rionero In Vulture, Italy
[6] IRCCS Canc Inst, Bari, Italy
[7] Hosp Di Venere, Bari, Italy
[8] Univ Hematol, Bari, Italy
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S248 / S248
页数：1
相关论文
共 50 条
  • [21] Overall survival in advanced stage mantle cell lymphoma after early autologous stem cell transplantation with cisplatin, etoposide, cytarabine and melphalan (peam) as a conditioning regimen
    Franco-Saenz, D.
    Acosta-Maldonado, B. L.
    Tellez-Manriquez, J. F.
    Valero-Saldana, L. M.
    Gutierrez-Gutierrez, B.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 171 - 171
  • [22] Busilvex in combination with etoposide and melphalan as conditioning regimen in autologous haematopoietic cell transplantation for lymphomas: efficacy and safety
    Sakellari, I.
    Mallouri, D.
    Constantinou, V.
    Baliakas, P.
    Iskas, M.
    Karypidis, K.
    Apostolou, C.
    Kaloyannidis, P.
    Batsis, I.
    Vadikoliou, C.
    Papaemmanouil, S.
    Palladas, P.
    Smias, C.
    Anagnostopoulos, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S450 - S450
  • [23] TECAM (thiotepa, etoposide, cyclophosphamide, Ara-c and melphalan) as conditoning regimen for autologous stem cell transplantation in patients with lymphoma
    Patir, P.
    Soyer, N.
    Sahin, F.
    Saydam, G.
    Tobu, M.
    Tombuloglu, M.
    Vural, F.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S336 - S337
  • [24] FEASIBILITY AND SAFETY OF BENDAMUSTINE, ETOPOSIDE, CYTARABINE, MELPHALAN (BEEAM) CONDITIONING REGIMEN BEFORE AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN 33 PATIENTS WITH MALIGNANT LYMPHOMA
    Bedoui, M.
    Brault, P.
    Glaisner, S.
    Shamieh, R. Elias
    Kuhnowski, F.
    HAEMATOLOGICA, 2016, 101 : 861 - 861
  • [25] Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen
    Farnault, L.
    Venton, G.
    Pourroy, B.
    Jourde-Chiche, N.
    Ivanov, V.
    Arcani, R.
    Roche, P.
    Mercier, C.
    Colle, J.
    Fanciullino, R.
    Costello, R. T.
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1173 - 1175
  • [26] Overall Survival in Advanced Stage Mantle Cell Lymphoma after Early Autologous Stem Cell Transplantation with Cisplatin, Etoposide ,Cytarabine and Melphalan (PEAM) As a Conditioning Regimen
    Franco, Daniel
    Tellez, Fernando
    Solis-Armenta, Ruben
    Leal Alanis, Araceli
    Cruz Castillo, Carlos
    Valero Saldana, Luis Manuel
    Acosta Maldonado, Brenda Lizeth
    BLOOD, 2023, 142
  • [27] Severe renal insufficiency is not an absolute pitfall to autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) conditioning regimen
    L. Farnault
    G. Venton
    B. Pourroy
    N. Jourde-Chiche
    V. Ivanov
    R. Arcani
    P. Roche
    C. Mercier
    J. Colle
    R. Fanciullino
    RT Costello
    Bone Marrow Transplantation, 2019, 54 : 1173 - 1175
  • [28] Clinical and safety outcomes of BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) versus CEM (Carboplatin, Etoposide, Melphalan) in lymphoma patients as a conditioning regimen before autologous hematopoietic cell transplantation
    Eltelbanei, Mohamed A.
    El-Bassiouny, Noha A.
    Abdalla, Mahmoud Salah
    Khalaf, Mohamed
    Werida, Rehab H.
    BMC CANCER, 2024, 24 (01)
  • [29] Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma
    Keil, F.
    Noesslinger, T.
    Unteregger, M. J.
    Moestl, M.
    Tinchon, C.
    Koller, E.
    Mulabecirovic, A.
    Hundsamer, A.
    Linkesch, W.
    ONKOLOGIE, 2012, 35 : 42 - 42
  • [30] Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma
    Noesslinger, T.
    Keil, F.
    Moestl, M.
    Tinchon, C.
    Koller, E.
    Mulabecirovic, A.
    Unteregger, M. J.
    Hundsamer, A.
    Sallaberger, E.
    Linkesch, W.
    ONKOLOGIE, 2013, 36 : 7 - 7
12345